Comprehensive Analysis of SARS-CoV-2 Persistence in the Human Body and Brain

A recent study “SARS-CoV-2 infection and persistence in the human body and brain at autopsy” has provided substantial insights into the behavior of the SARS-CoV-2 virus, responsible for COVID-19, particularly its persistence in the human body and brain.

Here are the key findings from this comprehensive research:

  1. Widespread Distribution and Persistence of the Virus: The study, which involved complete autopsies on 44 patients who died from COVID-19, reveals that SARS-CoV-2 is widely distributed across the human body, including the brain. The virus was present in multiple respiratory and non-respiratory tissues, with evidence of viral replication in early stages of infection. Notably, SARS-CoV-2 RNA was detected in various anatomic sites, including the brain, as late as 230 days after symptom onset in one case.
  2. Little Evidence of Inflammation Outside the Respiratory Tract: Despite the widespread distribution of the virus, there was minimal evidence of inflammation or direct viral damage outside the respiratory tract. This finding challenges the understanding of the virus’s impact on extrapulmonary organs.
  3. Subgenomic RNA Detection Indicating Active Viral Replication: The detection of subgenomic RNA across all tissue groups suggests that viral replication may occur in non-respiratory tissues for several months. This finding is crucial in understanding the long-term effects of COVID-19.
  4. Impact on the Central Nervous System (CNS): The study employed in situ hybridization (ISH) to confirm the presence of SARS-CoV-2 spike RNA in both respiratory and non-respiratory tissues, including various regions of the brain. This extensive analysis emphasizes the virus’s ability to infect the CNS.
  5. Histopathological Findings: Among the 44 cases studied, the majority who died from COVID-19 exhibited acute pneumonia or diffuse alveolar damage. Interestingly, in the examination of 11 brains, few histopathologic changes were observed despite a substantial viral burden.
  6. Early Dissemination and Persistent RNA: The research shows early dissemination of the virus in some patients, with a significantly higher viral load in respiratory tissues compared to non-respiratory tissues. However, this difference diminished over time in late cases, suggesting less efficient viral clearance in non-respiratory tissues.
  7. Challenges in Viral Clearance: The study highlights the challenges in clearing the virus from various tissues, which might be due to the virus’s ability to alter cellular mechanisms and evade immune detection.
  8. Study Limitations: The study primarily involved older, unvaccinated individuals with pre-existing medical conditions who died from severe COVID-19. Therefore, the findings might not be fully generalizable to younger, healthier, or vaccinated individuals or to current and future variants of SARS-CoV-2.

In conclusion, this study significantly advances the understanding of SARS-CoV-2’s behavior, particularly its ability to persist in the human body and brain. It underscores the need for further research to explore the mechanisms of viral persistence and its contribution to the long-term effects of COVID-19​​​​.

Read More: https://nature.com/articles/s41586-022-05542-y

Leave a comment